ALBPS — Biophytis SA Cashflow Statement
0.000.00%
Last trade - 00:00
- €1.45m
- €5.65m
C2018 December 31st | 2019 December 31st | C2020 December 31st | 2021 December 31st | 2022 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | -14 | -17.8 | -25.5 | -31.2 | -24.2 |
Depreciation | |||||
Non-Cash Items | 0.368 | 1.45 | 11.1 | 7.19 | 4.21 |
Other Non-Cash Items | |||||
Changes in Working Capital | 1.33 | 0.808 | 4.44 | -0.052 | 0.54 |
Change in Accounts Receivable | |||||
Change in Prepaid Expenses | |||||
Change in Other Assets | |||||
Change in Accounts Payable | |||||
Change in Accrued Expenses | |||||
Change in Other Liabilities | |||||
Net Change in Other Assets & Liabilities | |||||
Other Operating Cash Flow | |||||
Cash from Operating Activities | -12.1 | -15.3 | -9.74 | -23.8 | -19 |
Capital Expenditures | -0.113 | -0.282 | -0.214 | -0.344 | -0.141 |
Purchase of Fixed Assets | |||||
Other Investing Cash Flow Items | 0.009 | 0.004 | -12.5 | 12.5 | 0.124 |
Sale/Maturity of Investment | |||||
Purchase of Investments | |||||
Other Investing Cash Flow | |||||
Cash from Investing Activities | -0.104 | -0.278 | -12.7 | 12.2 | -0.017 |
Financing Cash Flow Items | -0.122 | 3.35 | -6.87 | -4.37 | -1.29 |
Other Financing Cash Flow | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | 6.77 | 7.5 | 22 | 29.7 | 6.13 |
Foreign Exchange Effects | |||||
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | -5.45 | -8.07 | -0.49 | 18.1 | -12.9 |